THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Newtyn Management, LLC's Holding History (CIK: 0001569241)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,300,000 Value ($000) $80,453 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 4,950,000 Value ($000) $72,270 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 4,950,000 Value ($000) $54,599 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 4,757,403 Value ($000) $42,484 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 4,757,403 Value ($000) $44,767 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 4,499,066 Value ($000) $36,262 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 2,124,703 Value ($000) $18,017 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 1,643,930 Value ($000) $14,746 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 1,900,000 Value ($000) $21,356 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 1,841,560 Value ($000) $15,893 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 1,640,456 Value ($000) $16,979 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 1,531,015 Value ($000) $16,612 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 1,450,000 Value ($000) $16,269 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 2,495,860 Value ($000) $25,308 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 2,037,825 Value ($000) $18,463 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 1,375,000 Value ($000) $13,145 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 1,000,000 Value ($000) $11,050 Avg Close $8.72 Range $7.30 - $11.24
Q3 2021
Shares 97,955 Value ($000) $725 Avg Close $11.19 Range $6.10 - $15.01
Q4 2019
Shares 173,300 Value ($000) $4,487 Avg Close $19.43 Range $15.72 - $26.47
Q3 2019
Shares 63,681 Value ($000) $1,241 Avg Close $20.20 Range $16.00 - $24.34